At that time, I didnt know that having toxins on board was actually delaying my healing
Mild side effects can include short-term injection-site redness and very rarely transient mild headache in the first week
10.1038/82732 78 HouJ.LeiZ.CuiL.HouY.YangL.et al (2021)
doi: 10.1371/journal.pone.0021827 277 ToK.CaoR.YegiazaryanA.OwensJ.NguyenT.SasaniniaK.et al
There are currently ongoing observational studies and early-phase clinical investigations of BPC-157 in gastrointestinal disease, reflecting the strength of the gut healing literature and the relative accessibility of GI endpoints in human trials
BPC-157 may not be appropriate when: Imaging or specialist review has not yet been completed for a suspected structural injury There are acute red flag features (severe weakness, fever, rapid unexplained swelling, neurological changes, unexplained weight loss) The patient has active cancer or a history of certain cancers where angiogenic peptides require careful risk assessment The goal is rapid results without addressing underlying load, rehabilitation, or lifestyle drivers A peptide should not be used to delay evaluation that is clearly warranted
